Comparison of MR Spectroscopy, 2-Point Dixon, and Multi-Echo T2*Sequences in Assessing Hepatic Fat Fraction Across a Diverse Range of Body Mass Index (BMI) and Waist Circumference Ratio (WCR) Values

被引：0

作者：

Brzeska, Beata ^{[1
]}

Sabisz, Agnieszka ^{[1
]}

Kozak, Oliwia ^{[2
]}

Szurowska, Edyta ^{[1
]}

Pienkowska, Joanna ^{[1
]}

机构：

[1] Med Univ Gdansk, Fac Hlth Studies, Dept Radiol 2, Gdansk, Poland

[2] Med Univ Gdansk, Fac Med, Dept Radiol 1, Gdansk, Poland

来源：

DIABETES METABOLIC SYNDROME AND OBESITY | 2025年 / 18卷

关键词：

magnetic resonance imaging; 1HNMR liver spectroscopy; hepatic steatosis; LIVER-DISEASE; QUANTIFICATION; STEATOSIS; MUSCLE;

D O I：

10.2147/DMSO.S481062

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: The study aimed to compare and evaluate the accuracy of three magnetic resonance imaging (MRI) sequences-MR liver spectroscopy, 2-point Dixon, and multi-echo T2*-in assessing hepatic fat fraction in patients with various body mass indexes (BMIs). Methods: 167 participants were recruited, including 110 healthy subjects with diverse BMIs and 57 bariatric surgery candidates. The MRI protocol involved three sequences: multi-echo single voxel STEAM 1H spectroscopy, 2-point mDixon, and multi-echo T2* sequence. Hepatic fat fraction was measured using these sequences and analyzed statistically to determine correlations and agreement between the methods. Results: A strong positive correlation was observed between BMI and waist circumference ratio (WCR) (rs(165) = 0.910, p<0.001). MRS obtained hepatic fat fraction numerical values in 13.33% of the normal BMI group, 48.48% of the overweight group, and 72.97% of the obese group. Strong correlations were found between all methods, with significant agreement, particularly between MRS and multi-echo T2*. Conclusion: Robust correlations were observed between MR spectroscopy, 2-point Dixon, and multi-echo T2* methods for liver fat fraction measurement, especially in patients with higher BMI and WCR. These findings highlight the importance of BMI and WCR in interpreting fat fraction measurements, as method performance can vary across body composition profiles.

引用

页码：601 / 614

页数：14

共 30 条

[1] Obesity and overweight, (2021)
[2] Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L., The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review, Hepatology, 77, 4, pp. 1335-1347, (2023)
[3] Cornier MA, Dabelea D, Hernandez TL, Et al., The metabolic syndrome, Endocr Rev, 29, pp. 777-822, (2008)
[4] Nilsson PM, Tuomilehto J, Ryden L., The metabolic syndrome – what is it and how should it be managed?, Eur J Prev Cardiol, 26, pp. 33-46, (2019)
[5] Adams LA, Lymp JF, St. Sauver J, Et al., The natural history of nonalcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 129, pp. 113-121, (2005)
[6] Day CP, Anstee QM., Nonalcoholic fatty liver disease, Semin Liver Dis, 35, pp. 203-206, (2015)
[7] Camhi SM, Bray GA, Bouchard C, Et al., The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences, Obesity, 19, (2011)
[8] Semmler G, Balcar L, Wernly S, Et al., Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease, Front Endocrinol, 14, (2023)
[9] Ariya M, Koohpayeh F, Ghaemi A, Et al., Assessment of the association between body composition and risk of non-alcoholic fatty liver, PLoS One, 16, (2021)
[10] Wu Y, Li D, Vermund SH., Advantages and limitations of the body mass index (BMI) to assess adult obesity, Int J Environ Res Public Heal, 21, (2024)

← 1 2 3 →